We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

The fire lighter?

21 August 2009 By Una Galani

The German drug wholesaler may be floated with a E6bn pricetag as part of the restructuring of the Merckle empire. A trade sale remains likely, and the mooted valuation looks toppy. But if markets hold up, a big European IPO could be the green light for a host of new issues.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)